化学
癌症研究
放射增敏剂
放射治疗
适体
体内
转移
癌症
癌细胞
下调和上调
肿瘤进展
细胞
肿瘤细胞
转染
DNA
遗传增强
癌症治疗
细胞生长
联合疗法
信号转导
基因
作者
Miao Li,Dandan Fan,Sin Yu Lam,Zhixin Han,Tang Tang,Jieyu Zhao,Xiaju Cheng,Danyang Ji,Chun Kit Kwok,Haibin Shi
摘要
Abstract The hypoxia-inducible factor (HIF) coordinates the response of tumors to low oxygen by stimulating genes involved in metabolism and angiogenesis. HIF pathway activation is highly associated with tumor progression and radiotherapy resistance. Ligands that target this pathway are potential agents for the treatment of solid tumor malignancies. We developed an L-RNA aptamer, L-Apt5–4, targeting the HIF-1α promoter DNA G-quadruplex (dG4) via mirror-image SELEX. This L-RNA aptamer adopts a stem-loop secondary structure, binds HIF-1α dG4 with high affinity and specificity, and enters the nucleus to effectively downregulate HIF-1α and its downstream targets in cancer cells. By suppressing HIF-1α, L-Apt5–4 not only inhibits tumor cell proliferation, migration, and invasion, but also acts as a potent radiosensitizer, synergizing with radiotherapy to enhance cancer cell death. The combination therapy significantly suppresses tumor growth and metastasis while exhibiting excellent biosafety in vivo. Thus, L-Apt5–4 represents a novel HIF-1α-targeted therapeutic and radiosensitizer for combined cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI